| 2002 |
MR Imaging and MR Spectroscopic Imaging of Prostate Cancer
Prior to Radical Prostatectomy: A Prospective Multi-Institutional
Clinicopathological Study.
ACRIN 6659 |
Role: Institutional JHU PI |
| 2002 |
Comparison of Novel PET/CT Imaging Agents and MR/MRS Metastatic
and High Risk Prostate Cancer. NCI Mayo/Hopkins SPORE |
Role: Consultant |
| 2002 |
AUS Clinical Trial Site to Conduct Evaluations of Topical
Microbicides. Center for Disease Control, Contract 200-2001-08015 |
Role: Consultant |
| 2003 |
Phase I, Pharmacological and Biological Study of OSI-774
in Combination with FOLFOX 4 in patients with Advanced Colorectal
Cancer. NCI Protocol 5869 |
Role: Collaborator |
| 2003 |
Role of MR Imaging in Assessment of Urethral Sphincter
Morphology and Function in Continent and Incontinent Women.
Radiological Society of North America (RSNA) |
Role: PI |
| 2004 |
Quantitative 23namri Of Breast Cancer, NCI Protocol #
R21CA095907 |
Role: Collaborator
|
| 2006 |
ARRS SCHOLARSHIP PROGRAM Becoming a Translational Researcher In Prostate Cancer Imaging |
Role: PI |
| 2007 |
The Institute for Clinical and Translational Research (ICTR) |
Role:
Co-Investigator (Imaging Core Leader allocation) |
| 2007 |
Proton MRSI of Human Breast Cancer at 3 and 7 Tesla |
Role: Co-Investigator |
| 2008 |
Johns Hopkins University In Vivo Cellular and Molecular Imaging Center |
Role: Co-Investigator (allocation) |
| 2008 |
Using Multiparametric MR Imaging for MR-Guided Biopsy of the
Prostate |
Role:PI |
| 2008 |
Imaging the Interaction Between Hypoxia and Cancer Stem Cells |
Role: Co-Investigator |
